Pharma Journalist -

U.S FDA has accepted the IND application for ASN007, a selective ERK ½ inhibitor as declared by Asana BioSciences which specialises in oncology nd a clinical stage biopharmaceutical…
Read More...

Genecentric Therapeutics Inc. Proclaimed a research collaboration to assess the potential of Genecentric’s Cancer Subtype Platform in order to detect responders to G1 Therapeutic’s oral…
Read More...

Novaquest Capital Management announced acquisition of Viamet Pharmaceuticals including the company’s product candidate, VT-1161 that successfully complete phase 2b clinical trials for…
Read More...

ArunA Biomedical officially launches of a new class exosome biologics to cure central nervous system and neurogenerative disorders. The company published conclusions of a study…
Read More...

Clinical biopharmaceutical company, Liquidia dedicated to accelerate the performance of precision medicine by accurately engineering drug particles announces to commence the evolution…
Read More...

Pharmaceutical Product Development, LLC asserts Colin Hill, an acclaimed name in the health care technology and a connoisseur in precision medicine to its board of directors. He is…
Read More...

Leading venture backed microbiome company growing novel molecular therapeutics based on the human microbiome, asserted that it intends to enter into an agreement with Paragon…
Read More...

Advanced precision medicine CIRCULOGENE through its molecular genetics testing enters into an international licensing agreement with turkey based CIRCULOGENE Saglik. As per the terms…
Read More...

CanniMed Therapeutics Inc’s wholly owned subsidiary Sub Terra LLC moves to produce and process medical cannabis through its State of Michigan licenses application. The company has…
Read More...

Ophthalmic medical technology company Glaukos Corporation committed to the development of world-class products aiming to revolutionise the treatment of Glaucoma declared that it has…
Read More...